SCHEMBL2132797

SCHEMBL2132797

CCOC(=O)C1C(C)=CC=CC1(C)C

nearest known ligand 0.36

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.36
POLB P06746 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
LMNA P02545 3/20 0.35
TSHR P16473 4/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 2/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11526857 0.84 LMNA (0.33) ALDH1A1POLBL3MBTL1LMNATSHR
SCHEMBL1686188 0.81 ALDH1A1 (0.33) ALDH1A1POLBL3MBTL1LMNATSHR
SCHEMBL3639641 0.78 ALDH1A1 (0.39) ALDH1A1POLBL3MBTL1TSHRMEN1
SCHEMBL31534652 0.75 DNTT (0.41) ALDH1A1POLBL3MBTL1LMNATSHR
SCHEMBL31534654 0.75 DNTT (0.41) ALDH1A1POLBL3MBTL1LMNATSHR
SCHEMBL24220059 0.69 ALDH1A1 (0.41) ALDH1A1POLBL3MBTL1LMNATSHR
SCHEMBL30311955 0.69 LMNA (0.50) ALDH1A1LMNATSHRHSD17B10TP53
SCHEMBL10655589 0.68 ALDH1A1 (0.46) ALDH1A1POLBL3MBTL1TSHRMEN1
SCHEMBL861375 0.67 ADORA3 (0.36) ALDH1A1POLBLMNATSHRMEN1
SCHEMBL812163 0.66 LMNA (0.43) ALDH1A1LMNATSHRMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 335 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250163343-A1 FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT INTERNATIONAL FLAVORES & FRAGRANCES INC. 2025-05-22 US claimed
US-20250129312-A1 CONSUMER PRODUCT COMPOSITIONS WITH PERFUME ENCAPSULATES PROCTER & GAMBLE (US) 2025-04-24 US claimed
US-12209232-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2025-01-28 US claimed
EP-4486857-A1 FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT International Flavors & Fragrances Inc. (US) 2025-01-08 EP claimed
US-20240197221-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-20 US claimed
US-20240197243-A1 FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2024-06-20 US claimed
US-20240173230-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2024-05-30 US claimed
EP-4347757-A1 FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING Givaudan SA (CH) 2024-04-10 EP claimed
EP-4347758-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING Givaudan SA (CH) 2024-04-10 EP claimed
EP-4319715-A1 FRAGRANCE COMPOSITION Givaudan SA (CH) 2024-02-14 EP claimed
WO-2023168069-A1 FRAGRANCE COMPOSITIONS FOR SLEEP IMPROVEMENT INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) 2023-09-07 WO claimed
US-11732222-B2 Consumer product compositions with perfume encapsulates THE PROCTER & GAMBLE COMPANY (US) 2023-08-22 US claimed
US-20220411718-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY 2022-12-29 US claimed
WO-2022271929-A1 DETERGENT COMPOSITIONS THE PROCTER & GAMBLE COMPANY (US) 2022-12-29 WO claimed
EP-4108752-A1 DETERGENT COMPOSITIONS The Procter & Gamble Company (US) 2022-12-28 EP claimed
US-20220364016-A1 PERFUME OIL MIXTURE SYMRISE AG (DE) 2022-11-17 US claimed
WO-2022234149-A1 FRAGRANCE FOR IMPROVING RELAXATION STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 WO claimed
WO-2022234150-A1 FRAGRANCE FOR IMPROVING HAPPINESS STATE AND METHOD OF ASSESSING GIVAUDAN SA (CH) 2022-11-10 WO claimed
WO-2022214636-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2022-10-13 WO claimed
EP-4025675-A1 A PERFUME OIL MIXTURE Symrise AG (DE) 2022-07-13 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240173230-A1 FRAGRANCE COMPOSITION FABP2, FABP5, FAAH2 ALDH1A1 413/4885POLB 766/4885L3MBTL1 2882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.